Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
34.57
+0.18 (0.52%)
Mar 4, 2026, 12:49 PM EST - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Biotechnology
276.26M237.22M197.52M164.37M156.18M
Biotechnology Growth
16.45%20.10%20.17%5.24%25.77%
Total
276.26M237.22M197.52M164.37M156.18M
Total Growth
16.45%20.10%20.17%5.24%25.77%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
276.26M237.22M197.52M164.37M156.18M
United States Growth
16.45%20.10%20.17%5.24%25.77%
Total
276.26M237.22M197.52M164.37M156.18M
Total Growth
16.45%20.10%20.17%5.24%25.77%
Source: S&P Global Market Intelligence.